05/02/2024 6:01 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024 6:02 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024 4:03 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 3:24 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 6:01 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/05/2024 4:04 PM | Eupraxia Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/05/2024 6:02 AM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 1:59 PM | Eupraxia Pharmaceuticals (Filer)
| Form CERT | |
04/03/2024 4:00 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/18/2024 3:30 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/15/2024 3:48 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2024 3:30 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024 4:27 PM | Eupraxia Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/07/2024 11:15 PM | Eupraxia Pharmaceuticals (Filer)
| Form EFFECT | |
02/05/2024 3:01 PM | Eupraxia Pharmaceuticals (Filer)
| Form F-10/A | |
01/18/2024 4:23 PM | Eupraxia Pharmaceuticals (Filer)
| Form 8-A12B | |
01/18/2024 3:30 PM | Eupraxia Pharmaceuticals (Subject)
| Form F-X Appointment of agent for service of process and undertaking | |
08/22/2023 4:03 PM | Eupraxia Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |